Home Top Movers Why Marker Therapeutics Inc (MRKR) stock surged on Thursday?

Why Marker Therapeutics Inc (MRKR) stock surged on Thursday?

Marker Therapeutics Inc (MRKR) stock had a good Thursday, April 22. In the normal trading session, MRKR stock gained 3.38% and, in the after-hours, it kept its momentum going and surged 7.01%. MRKR shares have risen by 4.90% over the last 12 months, and they have moved up by 2.39% in the past week. Over the past three months, the stock has gained 5.42%, while over the past six months, it has added 27.38%.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Let’s check Marker Therapeutics recent news.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Closing public offering of MRKR common stock

On March 16, 2021, Marker Therapeutics, Inc. closed an underwritten public offering of 32,282,857 shares of its common stock at a public offering price of $1.75 per share.

The gross proceeds of approximately $56.5 million are expected from the offering.

Participation in the investor conference

Marker Therapeutics recently participated in the virtual Oppenheimer 31st Annual Healthcare Conference which held on Wednesday, March 17, 2021, at 3:10 p.m. ET.

Peter L. Hoang, President and Chief Executive Officer of Marker Therapeutics represented the company.

Read More

Latest financial results

On March 9, 2021 /PRNewswire/ – Marker Therapeutics, Inc. announced its financial results for the fiscal year ended December 31, 2020.

FY 2020 financial highlights

  • Marker suffered a net loss of $28.7 million for FY 2020 compared to a net loss of $21.4 million for FY 2019.
  • Marker Therapeutics spent $18.9 million in research and development expenses for the FY 2020, compared to $12.8 million for the year ended December 31, 2019.
  • General and administrative expenses were $10.5 million for the year ended December 31, 2020, compared to $10.0 million for the year ended December 31, 2019.
  • Marker had cash and cash equivalents of $21.4 million as of December 31, 2020.

 The first Patient received the dose of MT-401 in the phase 2 trial

On March 3, 2021, Marker Therapeutics, Inc. announced that in the phase 2 trial, the first patient received the dose of MT-401, its lead MultiTAA-specific T cell product candidate.

The phase 2 trial is enrolling patients with acute myeloid leukemia (AML) following an allogeneic stem cell transplant in both the adjuvant and active disease settings.

New manufacturing facility completion

On January 13, 2021, Marker Therapeutics, Inc. announced the construction completion and qualification of its cGMP manufacturing facility in Houston, TX, located near the George Bush Intercontinental Airport.

The new facility is expected to be fully operational in the first half of 2021 and will be used for the production of MultiTAA-specific T cell products according to FDA guidelines.

FDA lifted the partial hold on the Phase 2 trial of MT-401

On January 5, 2021, Marker Therapeutics, Inc announced that the partial clinical hold on the Company’s Phase 2 trial investigating the safety and efficacy of MT-401 has been lifted by the FDA

MT-401 is Marker’s lead multi-tumor-associated antigen (MultiTAA)-specific T cell product candidate for the treatment of post-transplant acute myeloid leukemia (AML).

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

Well, we have no recent news in the market to justify its gains on Thursday but the company is performing well and we can expect that it will continue its positivity on Friday as well.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Explains MOGO Stock Going Up Today?

The Mogo Inc. (NASDAQ: MOGO) stock has gained 5.04% to $8.55 in premarket trading today. Mogo stock finished last trading day at $8.14, down...

Zynga Inc. (ZNGA) stock rises in the Pre-Market: What’s going on?

Zynga Inc. (ZNGA) announced its first-quarter 2021 financial results after which the ZNGA stock happened to be green after underperformance in the last trade....

American Shared Hospital Services (AMS) Stock Continues to Soar Following Unprecedent Volumes Being Traded

American Shared Hospital Services (AMS) stock prices surged by 30.51% as of market close on May 5th, 2021, bringing the price per share up...

James River Group Holdings Ltd. (NASDAQ: JRVR) stock falls during pre-market. Why is it so?

James River Group Holdings Ltd. (NASDAQ: JRVR) stock plunged by 1.67% at last close while the JRVR stock continued decline by 25.74% at last...

Aviat Networks, Inc. (AVNW) Stock Trending Up After Promising Financial Reports for Most Recent Quarter

Aviat Networks, Inc. (AVNW) stock prices were up 3.81% as of market close on May 5th 2021, bringing the price per share up to...

Ambev S.A. (ABEV) Stock Trends Up Following Highly Promising Earnings Call for Q4 2020

Ambev S.A. (ABEV) stock prices were up 10.3943% shortly after the market opened on May 6th, 2021, bringing the price per share up to...

Sally Beauty Holdings (NYSE:SBH) stock surged in the current trading session; here’s why

In the current trading session, Sally Beauty Holdings Inc. (SBH) stock had surged by 19.69% to $24.25 at the time of writing. SBH stock...

Moderna Inc. (NASDAQ: MRNA) stock declines during current market. Let’s figure out why?

Moderna Inc. (NASDAQ: MRNA) stock falls by 5.31% in the current market trading after MRNA has announced its financial results for Q1 2021. Moderna...

Related News

Himax Technologies, Inc. (HIMX) Stock Climbing After Promising Q1 2021 Financial Reports

Himax Technologies, Inc. (HIMX) stock prices were down by 6.97% as of the market closing on May 5th 2021, bringing the price per share...

Why BioCryst Pharmaceuticals, Inc. (BCRX) stock is climbing today?

BioCryst Pharmaceuticals, Inc. (BCRX) announced its first-quarter 2021 financial results after which the BCRX stock happened to be green as its per-share price went...

Precipio, Inc. (PRPO) Stock Trending Up Following Successful Launch of Covid-19 Antibody Testing Kit

Precipio, Inc. (PRPO) stock prices were down 3.62% as of the market closing on ay 5th 2021, bringing the price per hare down to...

Shares of Cinedigm Corp. (CIDM) are climbing high in the premarket. What’s Going On?

Cinedigm (NASDAQ:CIDM), a distributor of various movies, television and other digital content, managing a library of distribution rights to several thousand titles and different...

Why Stealth BioTherapeutics Corp (MITO) stock is soaring in Pre-Market today?

Stealth BioTherapeutics Corp (MITO) presented the data at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Virtual Annual Meeting, which is collected...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.